| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 10 Nov 2026 |
Form 4: Johnson B Kristine, Director
Sold 2,452 shares ($143K) |
| 06 Nov 2026 | 144 |
| 05 Nov 2026 |
Form 4: Privitera Salvatore, Chief Technical Officer
Sold 8,404 shares ($546K) |
| 04 Nov 2026 | 144 |
| 04 Nov 2026 | 10-Q |
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition
MASON, Ohio, November 3, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today anno... |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 05 Oct 2026 | SCHEDULE 13G/A |
| 24 Sep 2026 |
Form 4: Privitera Salvatore, Chief Technical Officer
Sold 4,519 shares ($271K) |
| 23 Sep 2026 | 144 |
| 14 Sep 2026 |
Form 4: Groves Regina E, Director
Sold 5,313 shares ($288K) |
| 11 Sep 2026 | 144 |
| 10 Sep 2026 |
Form 4: Privitera Salvatore, Chief Technical Officer
Sold 3,657 shares ($201K) |
| 08 Sep 2026 | 144 |
| 04 Sep 2026 |
Form 4: Privitera Salvatore, Chief Technical Officer
Sold 7,763 shares ($408K) |
| 02 Sep 2026 | 144 |
| 26 Aug 2026 |
Form 4: Dahlquist Karl S., Chief Legal Officer
Sold 9,370 shares ($458K) |
| 24 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
Loading...